Public perspective on potential treatment intervention harm in clinical trials-terminology and communication.
Rachel PhillipsDongquan BiBeatriz GoulãoMarie MillerMalak El-AskaryOluyemi FagbemiCurie FreebornMaria GiammettaNoura El MasriPeter FlockhartManos KumarMike MelvinDianne MurrayAnthony MyhillLaila SaeidShanice ThomasGraeme MacLennanVictoria CorneliusPublished in: Trials (2024)
This work provides a starting point on preferred terminology by patients and the public to describe potential harmful intervention effects. Whilst researchers have tried to seek agreement, public partners endorsed use of different terms for different situations. We highlight some key areas for improvement in public facing materials that are necessary to avoid miscommunication and incorrect perception of harm.
Keyphrases
- healthcare
- mental health
- clinical trial
- randomized controlled trial
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- adverse drug
- prognostic factors
- emergency department
- human health
- risk assessment
- hepatitis c virus
- study protocol
- patient reported outcomes
- antiretroviral therapy
- smoking cessation